CAMBRIDGE, Mass.--(BUSINESS WIRE)--Stemgent Inc. announced today that it has completed the sale of its stem cell reagents and services business to ReproCELL in a cash transaction for approximately $8.5 million. Stemgent is selling the stem cell reagent and services business in order to focus on expanding its human tissue-based brand, Asterand Biosciences. Asterand has operated successfully for many years and is a leading global provider of high quality, well characterized human tissue and human tissue-based research services which support drug discovery and development and biomarker development and validation. Concurrent with the sale, the Company name was changed to Asterand Biosciences, Inc.
Help employers find you! Check out all the jobs and post your resume.
